PreCharge: An Innovative Digital Program to Increase Coping, Resilience, and Health Care Engagement Among Cancer Previvors
Key facts
- Who runs it
- Pro-Change Behavior Systems
- Trial code
- Status
- Not yet recruiting
- People taking part
- 574 people, planned
- Started
- Nov 2026
- Expected to end
- Sept 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- PreCharge digital psychosocial support program
- Record updated
- 13 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Age 18 years or older
- Reside in the United States
- Self-report having a hereditary cancer syndrome
- Able to read and communicate in English
- Willing to receive text messages during the 6-month study period
- Score of 100 or less on the 12-item Cancer Behavior Inventory-Brief Version (CBI-B) at screening
Who cannot take part
- Self-reported personal history of cancer, except non-melanoma skin cancer
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if PreCharge helps adults cope with an inherited risk of cancer. PreCharge is a personalized online support program for people with a hereditary cancer syndrome. The study is for adults who have not had cancer, with an exception for non-melanoma skin cancer.
Read full original descriptionShow less
The main question the study aims to answer is:
• Does PreCharge help participants feel more confident in their ability to cope with their inherited cancer risk? Researchers will compare participants who use PreCharge with participants who do not use the program during the study. Researchers will also look at participants' resilience, anxiety, depressive symptoms, cancer worry, and overall well-being.
Participants will be assigned by chance to one of two groups. Participants in both groups will answer online surveys at the start of the study and about 3 and 6 months later.
* Participants in the PreCharge group will have access to the program for 6 months. They will receive text messages and can use the online program's information and activities. * Participants in the comparison group will have access to a webpage with mental health and hereditary cancer resources.
The 2 groups in the trial
- PreChargeTreatment being tested
Participants receive access to PreCharge, a personalized digital psychosocial support program, for six months. The program includes a web-based portal and text messages that provide tailored information, activities, and support. Participants complete study assessments at baseline and at three and six months.
Treatment: PreCharge digital psychosocial support program
- Assessment-Only ControlNo study treatment, for comparison
Participants complete study assessments at baseline and at three and six months. They do not receive access to the PreCharge program during the study. They have access to a static webpage with mental health and hereditary cancer resources.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 13 November 2026